期刊文献+

磁共振和CT导向下的微波消融技术在肺癌治疗中的应用

原文传递
导出
摘要 目的:探讨磁共振(MRI)和CT引导下微波消融(MWA)技术在肺癌治疗中的应用价值。方法:选取2018年11月至2020年8月在江苏省肿瘤医院行MWA治疗的患者共60例。根据患者所选择的定位方法分为A组(MRI定位)和B组(CT定位)。观察两组患者在治疗时的机器扫描次数,引导治疗的总扫描时间和微波针在病灶中的消融时间。结果:A组患者的机器扫描次数及引导治疗的总扫描时间显著低于B组患者,差异有统计学意义(均P<0.001)。结论:MRI引导的MWA是一种微创治疗肺肿瘤的方法,机器扫描次数少,引导治疗的总扫描时间短,无辐射。
出处 《现代医学》 2021年第7期737-741,共5页 Modern Medical Journal
基金 江苏省卫健委干部保健局课题(BJ18034) 江苏省科技厅项目(BE2017758)
  • 相关文献

参考文献5

二级参考文献37

  • 1Yasunori Minami,Masatoshi Kudo.Radiofrequency ablation of hepatocellular carcinoma:Current status[J].World Journal of Radiology,2010,2(11):417-424. 被引量:40
  • 2刘宝东,刘磊,胡牧,钱坤,李元博,王若天,支修益.CT引导下射频消融治疗肺内特殊部位恶性肿瘤的临床评价[J].结核病与肺部健康杂志,2013,2(1). 被引量:6
  • 3D Dimitroulopoulos,D Xinopoulos,K Tsamakidis,A Zisimopoulos,E Andriotis,D Panagiotakos,A Fotopoulou,C Chrysohoou,A Bazinis,D Daskalopoulou,E Paraskevas.Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: Randomized placebo-controlled trial[J].World Journal of Gastroenterology,2007,13(23):3164-3170. 被引量:18
  • 4Ramesh K. Ramanathan,Chandra P. Belani,Deepti A. Singh,Michael Tanaka,Heinz-Josef Lenz,Yun Yen,Hedy L. Kindler,Syma Iqbal,Jeff Longmate,Philip C. Mack,Georg Lurje,Regina Gandour-Edwards,Janet Dancey,David R. Gandara.A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer[J].Cancer Chemotherapy and Pharmacology.2009(4)
  • 5Sandrine Faivre,Eric Raymond,Eveline Boucher,Jean Douillard,Ho Y Lim,Jun S Kim,Magaly Zappa,Silvana Lanzalone,Xun Lin,Samuel DePrimo,Charles Harmon,Ana Ruiz-Garcia,Maria J Lechuga,Ann Lii Cheng.Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study[J].Lancet Oncology.2009(8)
  • 6Augusto Villanueva,Derek Y. Chiang,Pippa Newell,Judit Peix,Swan Thung,Clara Alsinet,Victoria Tovar,Sasan Roayaie,Beatriz Minguez,Manel Sole,Carlo Battiston,Stijn van Laarhoven,Maria I. Fiel,Analisa Di Feo,Yujin Hoshida,Steven Yea,Sara Toffanin,Alex Ramos,John A. Martignetti,Vincenzo Mazzaferro,Jordi Bruix,Samuel Waxman,Myron Schwartz,Matthew Meyerson,Scott L. Friedman,Josep M. Llovet.Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma[J].Gastroenterology.2008(6)
  • 7Hashem B. El-Serag,Jorge A. Marrero,Lenhard Rudolph,K. Rajender Reddy.Diagnosis and Treatment of Hepatocellular Carcinoma[J].Gastroenterology.2008(6)
  • 8Josep M. Llovet,Jordi Bruix.Novel advancements in the management of hepatocellular carcinoma in 2008[J].Journal of Hepatology.2008
  • 9Andrew X.Zhu,KeithStuart,Lawrence S.Blaszkowsky,AlonaMuzikansky,Donald P.Reitberg,Jeffrey W.Clark,Peter C.Enzinger,PankajBhargava,Jeffrey A.Meyerhardt,KerryHorgan,Charles S.Fuchs,David P.Ryan.Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma[J].Cancer.2007(3)
  • 10Pierre-A Clavien.Interferon: The Magic Bullet to Prevent Hepatocellular Carcinoma Recurrence After Resection?[J].Annals of Surgery.2007(6)

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部